All diseases or symptoms those need upper gastrointestinal endoscopy
Conditions
Interventions
muscle injection of butylscoporamine bromide before the procedure by tranoral endoscopy
no muscle injection of butylscoporamine bromide before the procedure by tranoral endoscopy
no muscle injection o
Sponsors
Dept of Int Med (gastroenterology), Tokai University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: written informed consent patients who need upper gastrointestinal endoscopy patients who can be injected butylscoporamine bromide
Exclusion criteria
Exclusion criteria: patients who have severe injury on important organs such as heart, blood, kidney and liver. patients who have allergy against lidocain or butylscoporamine bromide patients who have histories of abdominal surgery patients not proper for butylscoporamine bromide injection such as prostate hypertrophy, glaucoma or arrythmia patients who have bleeding tendency patients who are thought to be not proper for the trial by the concerned doctors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| saliva weight during the procedure gastric motility (contraction times of pyloric ring and antrum per 1 minute) | — |
Secondary
| Measure | Time frame |
|---|---|
| pain (by VAS scale and qestionnaire) electrogastrogram | — |
Countries
Japan
Contacts
Public ContactMasashi Matsushima
Tokai University School of Medicine Dept of Int Med (gastroenterology)
Outcome results
None listed